Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Wahl

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Cancer Research|May 18, 2021
A Complementary Strategy to Mitigate Radiation-Induced Cognitive DeclineNavyateja Korimerla, Daniel R Wahl
Brain Pathology (Zurich, Switzerland)|November 4, 2015
2-Hydoxyglutarate: D/Riving Pathology in gLiomaSDaniel R Wahl, Sriram Venneti
Molecular & Cellular Oncology|November 25, 2020
Purine metabolism promotes radioresistance and is a therapeutic target in glioblastomaWeihua Zhou, Daniel R Wahl
Cancers|August 28, 2019
Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment ResistanceWeihua Zhou, Daniel R Wahl
International Journal of Molecular Sciences|February 15, 2022
Interactions between Radiation and One-Carbon MetabolismNavyateja Korimerla, Daniel R Wahl
Advanced Drug Delivery Reviews|November 25, 2015
Integrating chemoradiation and molecularly targeted therapyDaniel R Wahl, Theodore S Lawrence
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence
Seminars in Radiation Oncology|December 4, 2021
Targeting Noncanonical Regulators of the DNA Damage Response to Selectively Overcome Cancer Radiation ResistanceDonna M Edwards, Corey Speers, Daniel R Wahl
Nature Metabolism|April 29, 2026
Brain cells refine nitrogen choice with maturityAndrew J Scott, Costas A Lyssiotis, Daniel R Wahl
Seminars in Radiation Oncology|September 14, 2016
Translation of Targeted Radiation Sensitizers into Clinical TrialsZachery R Reichert, Daniel R Wahl, Meredith A Morgan
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Cancer Research|May 18, 2021
A Complementary Strategy to Mitigate Radiation-Induced Cognitive DeclineNavyateja Korimerla, Daniel R Wahl
Brain Pathology (Zurich, Switzerland)|November 4, 2015
2-Hydoxyglutarate: D/Riving Pathology in gLiomaSDaniel R Wahl, Sriram Venneti
Molecular & Cellular Oncology|November 25, 2020
Purine metabolism promotes radioresistance and is a therapeutic target in glioblastomaWeihua Zhou, Daniel R Wahl
Cancers|August 28, 2019
Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment ResistanceWeihua Zhou, Daniel R Wahl
International Journal of Molecular Sciences|February 15, 2022
Interactions between Radiation and One-Carbon MetabolismNavyateja Korimerla, Daniel R Wahl
Advanced Drug Delivery Reviews|November 25, 2015
Integrating chemoradiation and molecularly targeted therapyDaniel R Wahl, Theodore S Lawrence
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence
Seminars in Radiation Oncology|December 4, 2021
Targeting Noncanonical Regulators of the DNA Damage Response to Selectively Overcome Cancer Radiation ResistanceDonna M Edwards, Corey Speers, Daniel R Wahl
Nature Metabolism|April 29, 2026
Brain cells refine nitrogen choice with maturityAndrew J Scott, Costas A Lyssiotis, Daniel R Wahl
Seminars in Radiation Oncology|September 14, 2016
Translation of Targeted Radiation Sensitizers into Clinical TrialsZachery R Reichert, Daniel R Wahl, Meredith A Morgan
Pageof 8